when to use 5-alpha-reductase inhibitors (Proscar, Avodart) or PSA screening to prevent prostate cancer

July 2009

See updated FDA information concerning the use of 5-alpha reductase inhibitors and increased risk of serious forms of prostate cancer

Experts are debating when to use 5-alpha-reductase inhibitors (Proscar, Avodart) or PSA screening to prevent prostate cancer.

Proscar and Avodart. These 5-alpha-reductase inhibitors can prevent prostate cancer due to their anti-androgen effects.

Statistically, you need to treat 71 men for up to 7 years to prevent one case of prostate cancer.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote